Iaso Pharmaceuticals Private Limited

Wholesale trading of pharmaceutical products, exporting to various markets.

2011 | Delhi (India) | Active
Last Updated:

Iaso Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 2.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 14 Year, 26 Days
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth -14.50%
  • Profit Growth -21.02%
  • Ebitda -38.39%
  • Net Worth 11.21%
  • Total Assets 8.96%

About Iaso Pharmaceuticals

Iaso Pharmaceuticals Private Limited (IPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 15 February 2011 and has a history of 14 years. Its registered office is in Delhi, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.

Narender Chopra and Keshav Chopra serve as directors at the Company.

Company Details

  • Location

    Delhi, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24232DL2011PTC214139

  • Company No.

    214139

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    15 Feb 2011

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Delhi

Industry

Pharma

What products or services does Iaso Pharmaceuticals Private Limited offer?

Iaso Pharmaceuticals Private Limited offers a wide range of products and services, including Pharmacy Dropshipper, Drop Shipping Services.

Company report

Iaso Pharmaceuticals Private Limited

Explore comprehensive data for Iaso Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Iaso Pharmaceuticals?

Executive Team (1)

NameDesignationAppointment DateStatus
Narender Chopra Country flag representing In Managing Director15-Feb-2011Current

Board Members (1)

NameDesignationAppointment DateStatus
Keshav Chopra Country flag representing In Director 15-Feb-2011Current

Financial Performance of Iaso Pharmaceuticals.

Iaso Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 14.5% decrease. The company also saw a substantial fall in profitability, with a 21.02% decrease in profit. The company's net worth Soared by an impressive increase of 11.21%.

Iaso Pharmaceuticals revenue growth over time
Iaso Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-14.50%
Revenue from Operations
-20.02%
Total Assets
8.96%
Profit or Loss
-21.02%
Net Worth
11.21%
EBITDA
-38.39%

What is the Ownership and Shareholding Structure of Iaso Pharmaceuticals?

In 2023, Iaso Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Iaso Pharmaceuticals?

Unlock and access historical data on people associated with Iaso Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Iaso Pharmaceuticals Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Iaso Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Iaso Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Iaso Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Iaso Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Iaso Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.

  • Director Appointment

    Keshav Chopra was appointed as a Director was appointed as a Director on 15 Feb 2011 & has been associated with this company since 14 years 26 days .

  • Director Appointment

    Narender Kumar Chopra was appointed as a Managing Director was appointed as a Managing Director on 15 Feb 2011 & has been associated with this company since 14 years 26 days .

  • Company Incorporation

    Iaso Pharmaceuticals Private Limited was registered on 15 Feb 2011 with Roc Delhi & aged 14 years 26 days as per MCA records.

Frequently asked questions

  • What is the Incorporation or founding date of Iaso Pharmaceuticals Private Limited?

    Iaso Pharmaceuticals Private Limited was incorporated on 15 Feb 2011.

  • What is authorized share capital and paid-up capital of Iaso Pharmaceuticals Private Limited?

    The authorized share capital of Iaso Pharmaceuticals Private Limited is ₹ 2.50 M and paid-up capital is ₹ 0.50 M.

  • Who are the current board members & directors of Iaso Pharmaceuticals Private Limited?

    Currently 2 directors are associated with Iaso Pharmaceuticals Private Limited.

    • Narender Kumar Chopra
    • Keshav Chopra
  • What is the registered address of Iaso Pharmaceuticals Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Iaso Pharmaceuticals Private Limited is G-10 11 Ground Floor Vardhman Ac Market, Vigyan Vihar India, New Delhi, 110092.

  • What is the corporate identification number (CIN) and company number of Iaso Pharmaceuticals Private Limited?

    The corporate identification number (CIN) of Iaso Pharmaceuticals Private Limited is U24232DL2011PTC214139 and the company number is 214139 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Iaso Pharmaceuticals Private Limited?

    The Official website of Iaso Pharmaceuticals Private Limited is https://www.iasopharmaceuticals.com

  • What has been the recent revenue trend for Iaso Pharmaceuticals Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Iaso Pharmaceuticals Private Limited has fallen by -14.50%.

  • What change has been observed in the net worth of Iaso Pharmaceuticals Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Iaso Pharmaceuticals Private Limited has experienced an upsurge of 11.21%.

  • When was the last Balance Sheet of Iaso Pharmaceuticals Private Limited filed with the ROC?

    The most recent Balance Sheet for Iaso Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial